Coalition of Cancer Cooperative Groups
Public records show a registered, tax-exempt organization in good standing.
What it says it does
THE PURPOSE OF THE COALITION IS TO IMPROVE THE SURVIVAL AND QUALITY OF LIFE FOR CANCER PATIENTS BY INCREASING THE PARTICIPATION IN CANCER CLINICAL TRIALS.
- Income
- $13.2 million
- Spending
- $12.8 million
- Spent on programs
- 74%
- Reserves
- 9.6 months of spending
- Largest source of income
- fees for its services, 86%
- Employees
- 75
- Highest pay
- $383,488, president
Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
Good: 83 out of 100. Higher than 62% of charities in its peer group (medical research, $10m to $100m).
Reserves
28 of 35Spendable reserves would cover 9.6 months of spending.
Debt
10 of 20It owes 47% of what it owns.
Living within its means
15 of 15Income exceeded spending by 3% of income.
Income trend
15 of 15Income rose 3% on the year before.
Spending floor
15 of 1574% of spending went to programs and raising each dollar of donations cost 0 cents.
Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
Strong: 95 out of 100. Higher than 37% of charities in its peer group (medical research, $10m to $100m).
Independent board
25 of 259 of 9 voting board members are independent.
Conflict of interest policy
15 of 15Has a written conflict of interest policy.
Whistleblower policy
8 of 8Has a written whistleblower policy.
Record keeping policy
7 of 7Has a written policy on keeping and destroying records.
Board minutes
5 of 5Keeps minutes of board meetings.
Board sees the tax return
10 of 10Gave the board a copy of this return before filing it.
Pay set independently
0 of 5Reports no independent review process for its chief executive's pay.
Independent check of accounts
15 of 15Its accounts were audited by an independent accountant.
No reported misuse
10 of 10Reports no diversion of assets, excess benefits or loans to insiders.
Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (5)
- $1.1 million spent. FEDERAL GRANTS - THE COALITION, THROUGH ITS FEDERAL FUNDING, SUPPORTS THE EFFORTS OF THE ECOG-ACRIN GROUP CO-CHAIR'S OFFICE THROUGH SUCH SERVICES AS CONTRACTING, GRANT AND FISCAL OVERSIGHT, LEGAL COUNSEL, COMMUNICATION, AND GENERAL ADMINISTRATION. FURTHERMORE, THE COALITION ASSISTS IN EXPEDITING THE DEVELOPMENT AND CONDUCT OF ECOG-ACRIN STUDIES, ASSISTS WITH THE DEVELOPMENT AND DISSEMINATION OF EDUCATIONAL MATERIALS FOR ONCOLOGISTS AND PATIENTS, WORKS TO IMPROVE PATIENT ACCRUAL TO ECOG-ACRIN TRIALS, AND COORDINATES THE ECOG-ACRIN SEMI-ANNUAL GROUP MEETINGS.
- $1.0 million spent. CANCER TRIALS SUPPORT UNIT (CTSU) - UNDER A SUBCONTRACT WITH WESTAT, INC. (ROCKVILLE, MD) THE COALITION PROVIDES PROFESSIONAL AND SUPPORT STAFF TO OPERATE AND MANAGE THE REGULATORY SUPPORT SYSTEM AND OTHER KEY FUNCTIONS OF THE CTSU (A MAJOR CLINICAL TRIAL PROGRAM OF THE NATIONAL CANCER INSTITUTE (NCI, U.S. DEPT OF HEALTH AND HUMAN SERVICES), UNDER WESTAT'S PRIME CONTRACT WITH NCI, NO. HHSN261200622012C, ADB NO. N02-CM-62212.
- $218,085 spent. PRIVATE FOUNDATION GRANTS - THROUGH A GRANT PROVIDED BY THE BREAST CANCER RESEARCH FOUNDATION, THE COALITION PROVIDES ASSISTANCE TO ECOG INVESTIGATORS WHO ARE CONDUCTING A STUDY ON LATE RELAPSE BREAST CANCER BY SERVING AS THE PRIME GRANTEE WHO IS RESPONSIBLE FOR LIAISING WITH THE GRANTOR, MONITORING GRANT PROGRESS AND SUBMITTING BI-ANNUAL REPORTS, DISSEMINATING GRANT FUNDING TO SUBCONTRACTORS FOR VARIOUS ASPECTS OF THE STUDY, AND DEVELOPING AND DISSEMINATING MATERIALS TO BOLSTER ACCRUAL TO THE STUDY.
- $7.2 million spent. INTERNET BASED PUBLIC SERVICE PROGRAMS PASS-THROUGH FUNDS TO NCI FUNDED NATIONAL CANCER CLINICAL TRIALS COOPERATIVE GROUPS AND SITES PAYMENTS OF ALLOCATED SHARED COSTS
- INTERNET BASED PUBLIC SERVICE PROGRAMS PASS-THROUGH FUNDS TO NCI FUNDED NATIONAL CANCER CLINICAL TRIALS COOPERATIVE GROUPS AND SITES PAYMENTS OF ALLOCATED SHARED COSTS
Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending June 2025.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since March 1998.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.